Discover 5 Top Startups developing Internal Medicine Solutions

Staying ahead of the technology curve means strengthening your competitive advantage. That is why we give you data-driven innovation insights into the healthcare industry. This time, you get to discover 5 hand-picked startups developing internal medicine solutions.

Global Startup Heat Map: 5 Top Internal Medicine Startups

The 5 internal medicine startups you will explore below are chosen based on our data-driven startup scouting approach, taking into account factors such as location, founding year, and relevance of technology, among others. This analysis is based on the Big Data & Artificial Intelligence (AI)-powered StartUs Insights Discovery Platform, covering over 1.3 million startups & scaleups globally.

The Global Startup Heat Map below highlights the 5 internal medicine startups & scaleups our Innovation Researchers curated for this report. Moreover, you get insights into regions that observe a high startup activity and the global geographic distribution of the 1.424 companies we analyzed for this specific topic.

VisCardia develops an Implantable Heart Failure Treatment Device

Heart failure is a common health concern among the elderly, as well as younger adults who are leading sedentary lifestyles. It not only has an impact on the person’s health but also on their finances. The associated healthcare costs are expensive or even unaffordable in some cases. Long-term, effective solutions for the treatment of heart failure reduce the financial burdens on patients in the current healthcare system.

US-based startup VisCardia develops an implantable device for heart failure treatment. It uses electrical stimulation delivered to the diaphragm, modulating intrathoracic pressure pulses on the cardiovascular system. The device uses proprietary algorithms to ensure that the pulses generated by the device supplement those generated by the heart. The implant is minimally invasive and requires only standard laparoscopic surgical methods which help to keep the cost low and encourage its adoption by cardiac experts.

Stuart Therapeutics provides a Therapeutic Platform for Eye Disease Treatment

A report in the leading health journal Lancet estimates the number of people globally affected by visual impairments to be 285 million. The elderly have a high risk of losing sight due to aging causing cells within the eye to decay or lose their regenerative properties. Therapeutic solutions target specific cells within the human eye to treat eye diseases such as age-related macular degradation.

Stuart Therapeutics is a US-based startup specializing in the field of therapeutic care for eye diseases. The startup’s PolyCol platform uses patented research to create therapeutics that act as a direct tissue reparative for collagen membranes and structures in the eye. This allows the cells to heal and recover at an accelerated pace in the case of ophthalmic diseases. The startup’s drug candidate, ST-100, is a fast-acting therapeutic that directly addresses the corneal tissue damage associated with dry eye disease

Shorla Pharma develops Oncology Products

The WHO estimated that cancer was the second leading cause of death globally with 9.6 million deaths in 2018. Cancer treatment is also complex as there is always a chance for the disease to recur later. According to the breast cancer research foundation, breast cancer is the most common type of cancer which affects women and the second global leading cancer. This is why startups and scaleups are developing treatments specifically targeting cancer in women.

Irish startup Shorla Pharma focuses on oncology products for women’s and pediatric cancer. The startup’s lead drug candidate, SH-105, is a breast and ovarian cancer drug. It also offers SH-110, an oral solution to treat glioblastoma, and SH-111, a treatment for T-cell leukemia. The startup’s products target oncology areas where existing treatments are limited, in shortage, or inadequate.

Orionis Biosciences advances Precision Medicine Drug Discovery

The development of therapeutic solutions is a slow and expensive process that requires specialized requirements or technology. Many healthcare research departments may have the required knowledge or expertise to develop innovative drugs, but lack the technology to conduct their research or develop the trial drugs. This is why startups are developing AI-based platforms that speed up drug discovery.

Belgian startup Orionis Biosciences develops two platforms for the discovery of therapeutics and precision medicines for specific diseases. A-Kine and Allo-Glue focus on cytokine drug development and genome-scale drug discovery, respectively. The startup’s pipeline includes solutions to overcome immunosuppressive tumor microenvironments in the treatment of cancer.

Skymedicine provides an Educational Platform for Internal Medicine

There are multiple educational applications and platforms geared towards a better learning experience for school-level academics. However, there is a distinct lack of such apps for medical studies due to the high degree of complexity. Startups are developing educational apps for internal medicine students, offering an alternative to rote learning.

Skymedicine is a US-based startup providing a web and mobile educational platform specializing in internal medicine. The application serves as an effective replacement to question banks and study guides for certification exams such as ABIM and AOBIM. It allows internal medicine interns and residents who would like to keep abreast of internal medicine concepts.

Discover more Healthcare startups

To keep you up-to-date on the latest technology and emerging solutions, we provide you with actionable innovation intelligence – quickly and exhaustively. You can download one of our free Healthcare Innovation Report and discover new business opportunities or save your time & let us look into your areas of interest. We provide you with an exhaustive overview of new startups, scaleups & emerging technologies that matter to you.